logo

For the Inventor, By the Inventor

Sudbury, MA, United States of America

Tao Wang

This inventor holds 9 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Astrazeneca Ab, Celgene Car LLC. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Wang. Retrieved from https://idiyas.com/inventor/tao-wang-k21oqxaj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 22.2

 

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 84(Granted Patents)


Location History:

  • Waltham, MA (US) (2009 - 2014)
  • Sudbury, MA (US) (2012 - 2021)

Company Filing History:

goldMedal7 out of 1,534 
 
Astrazeneca Ab
 patents
silverMedal2 out of 44 
 
Celgene Car LLC
 patents

Years Active: 2009-2021

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 11098061 - MK2 inhibitors and uses thereof (2021-08-24),
2. 10138256 - MK2 inhibitors and uses thereof (2018-11-27),
3. 8835465 - Pyrazolylaminopyridine derivatives useful as kinase inhibitors (2014-09-16),
4. 8486966 - 9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer (2013-07-16),
5. 8324252 - Pyrazolylaminopyridine derivatives useful as kinase inhibitors (2012-12-04),
6. 8129403 - Chemical compounds (2012-03-06),
7. 8114989 - Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors (2012-02-14),
8. 8088784 - 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer (2012-01-03),
9. 7622482 - Chemical compounds (2009-11-24),

Title: The Innovative Contributions of Tao Wang

Introduction

Tao Wang is a prominent inventor based in Sudbury, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of MK2 inhibitors. With a total of 9 patents to his name, Wang's work has the potential to impact various therapeutic areas.

Latest Patents

Wang's latest patents focus on MK2 inhibitors and their uses. The first patent provides compounds of formula V, or pharmaceutically acceptable salts thereof, which are useful as inhibitors of MK2 kinases. This invention includes compositions and methods of using these compounds. The second patent also centers on MK2 inhibitors, detailing compounds, compositions, and methods for their application.

Career Highlights

Throughout his career, Tao Wang has worked with notable companies such as AstraZeneca and Celgene Corporation. His experience in these leading pharmaceutical firms has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Wang has collaborated with talented individuals in his field, including Bin Wang and Michelle Lamb. These partnerships have fostered innovation and enhanced the development of his patented technologies.

Conclusion

Tao Wang's contributions to the field of pharmaceuticals, particularly through his patents on MK2 inhibitors, showcase his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…